Abstract
Over a decade of randomized controlled trial data shows that transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) yield similar outcomes for patients with symptomatic severe aortic stenosis (AS), regardless of surgical risk. The 2020 American College of Cardiology and American Heart Association guidelines recommend these options for patients aged 65 to 80. However, with limited supporting data, TAVR is increasingly performed on patients under 65. To address this, the leadership of the American College of Cardiology’s Cardiac Surgery Team and Interventional Cardiology Councils compiled relevant data into a decision-making tool to guide the treatment of young and low-risk AS patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1035-1040 |
| Number of pages | 6 |
| Journal | Journal of Thoracic and Cardiovascular Surgery |
| Volume | 170 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2025 |
Keywords
- aortic stenosis
- clinical practice guidelines
- heart valve team
- shared decision making
- surgical aortic valve replacement
- transcatheter aortic valve replacement
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Review of the decision making approach to treating young and low-risk patients with aortic stenosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS